Description
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Product Unit Size | Cost | Quantity | Stock |
|---|
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Cas No. | 1096708-71-2 |
|---|---|
| Purity | ≥98% |
| Formula | C17H12Cl2F3N7O2S |
| Formula Wt. | 506.30 |
| IUPAC Name | 2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5- chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide |
| Solubility | DMSO 100 mg/mL (197.51 mM) Ethanol 100 mg/mL (197.51 mM) Water Insoluble |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
http://clinicaltrials.gov/show/NCT01425008
Side chain attached to various taxanes.
Bcl-2, Bcl-xl, sialyl transferase inhibitor.
Valsartan impurity
Nucleoside (guanosine) analog; RT, guanylyl cyc...
Curcumin derivative.
Peptide, substance P analog; NK agonist.
Synthesis impurity
NSAID; COX-1/2 inhibitor.
Naphthalene; indirect STAT1 agonist.
Echinocandin
Smo inhibitor.
pan-RAF inhibitor
Thioamide; thyroid peroxidase inhibitor.
Cyclohexanecarboxylic acid found in various pla...
Cyclic depsipeptide is a secondary metabolite i...
STING antagonist
β-lactam cephalosporin; penicillin binding pro...
Endogenous peptide hormone fragment, involved i...
Notch inhibitor.
Protonophore; chitinase OvCHT1 inhibitor.